# FDA Inspection 961415 - Aspirus Riverview Hospital and Clinics - January 14, 2016

Source: https://www.keypedia.com/records/fda_inspections/aspirus-riverview-hospital-and-clinics/e362e147-a573-41cb-8f06-01274276d96c
Source feed: FDA_Inspections

> FDA Inspection 961415 for Aspirus Riverview Hospital and Clinics on January 14, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 961415
- Company Name: Aspirus Riverview Hospital and Clinics
- Inspection Date: 2016-01-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 883465 - 2014-06-20](https://www.keypedia.com/records/fda_inspections/aspirus-riverview-hospital-and-clinics/5d8c4b29-1aa0-41c2-9da0-da9ef6b653e4)
- [FDA Inspection 779608 - 2012-04-27](https://www.keypedia.com/records/fda_inspections/aspirus-riverview-hospital-and-clinics/d8f4535c-be47-4be9-8738-fc6f1c869788)
- [FDA Inspection 629334 - 2009-11-05](https://www.keypedia.com/records/fda_inspections/aspirus-riverview-hospital-and-clinics/d00b6f40-9e4a-4a2a-9f5f-9a61e166e3ee)

Company: https://www.keypedia.com/companies/aspirus-riverview-hospital-and-clinics/80c84967-63f9-4531-aba3-6bb012929e20

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d